News

  • Judge rebukes rugby brain injury legal teams over lack of progress

    A judge has again criticised both sides in the rugby brain injury cases as two landmark claims continue to make little progress. Senior master Jeremy Cook opened the latest case management hearings by reminding both defendants and claimants that "it won't have escaped anybody's notice that some of these claims are now over five years [...]

  • Blood test may predict decline after cardiac arrest

    A blood test taken 48 hours after cardiac arrest could help predict a survivor's long-term memory and thinking, researchers say. The study found that measuring neurofilament light chain, or NfL, was significantly better at predicting later memory and thinking problems than the blood marker now used by doctors. NfL is a protein released into the [...]

  • Clot buster may stop promising stroke medicine from working properly

    A clotbusting drug commonly used to treat ischemic stroke interacts negatively with a promising anti-inflammatory treatment (anakinra), underscoring the need to test new stroke therapies alongside existing standard care. According to The University of Manchester led study on mice, the timing of anakinra must be adjusted to avoid reducing the benefits of the clot‑busting therapy known [...]

  • Blood test predicts stroke 15 years before onset

    A blood test could predict stroke and other cardiovascular diseases up to 15 years before symptoms appear, researchers say. The tool, called CardiOmicScore, uses a single blood sample to generate personalised risk scores for six major cardiovascular conditions: coronary artery disease, stroke, heart failure, atrial fibrillation, peripheral artery disease and venous thromboembolism. The [...]

  • Tech enables rapid communication for two people with paralysis

    A brain implant has enabled two people with paralysis to communicate through rapid, accurate typing using attempted finger movements. The device was tested in two BrainGate clinical trial participants, one with advanced amyotrophic lateral sclerosis, or ALS, and the other with a spinal cord injury. A QWERTY keyboard was displayed in front of [...]

  • Trial will compare stimulation approaches to restoring touch after SCI

    A trial will compare three stimulation approaches to restore touch in people with quadriplegia after spinal cord injury. Quadriplegia, paralysis of all four limbs caused by spinal cord injury, can leave people unable to feel objects they are trying to grasp or the sensation of holding another person's hand. A US$3.1m grant from the Eunice [...]

  • Cholesterol drug could extend MND lifespan

    A forthcoming study will test whether statins, a cholesterol drug, could help people with MND live longer. There is no cure for MND, which causes muscle weakness, can lead people to lose the ability to walk and gets worse over time. People with the progressive neurodegenerative disease usually die within three to five years after [...]

  • Electrical stimulation and restore ability to move limbs after SCI – research

    Spinal stimulation may restore movement and sensation in people paralysed by spinal cord injury, a trial suggests. The clinical trial involved three people who had lost the use of their legs following complete spinal cord injuries. Participants received electrical stimulation of the spinal cord from electrode arrays implanted above and below their injury sites. [...]

  • Protein changes could predict post-stroke cognitive decline

    Protein changes after stroke could help identify people at risk of later memory and thinking problems, new research study suggests. The study also suggests smoking may increase the risk of memory and thinking problems alongside ongoing inflammation after a stroke. The research, published in Alzheimer’s & Dementia, is part of the Stroke IMPaCT study, a [...]

  • MJFF grants US$6.9m for OPM Parkinson’s trial

    A US$6.92m grant from the Michael J. Fox Foundation will help prepare OPM-201 for clinical studies in people with early Parkinson's disease. Oncodesign Precision Medicine has been awarded the research grant to prepare its LRRK2 inhibitor. A Phase 1b trial, along with a Phase 2 study, is expected to start in 2027. The funding follows OPM's [...]